Small cell carcinoma of the prostate expressing prostate-specific antigen and showing syndrome of inappropriate secretion of antidiuretic hormone: An autopsy case report

Pathology International

Volumn 53, Issue 12, 2003, Pages 892-896

  Kawai, Shigeo ^a   Hiroshima, Kenzo ^a   Tsukamoto, Yoshiaki ^b   Tobe, Toyofusa ^a   Suzuki, Hiroyoshi ^a   Ito, Haruo ^a   Ohwada, Hidemi ^a   Ito, Hisao ^a  

^a CHIBA UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Histogenesis; Immunohistochemistry; Neuroendocrine tumor; Prostate; Rosette formation; SIADH; Small cell carcinoma

Indexed keywords

BIOLOGICAL MARKER; PROSTATE SPECIFIC ANTIGEN; VASOPRESSIN;

AGED; ANTIGEN EXPRESSION; ARTICLE; AUTOPSY; BLADDER CARCINOMA; CANCER CELL; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CASE REPORT; CELL SIZE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); DEATH; DISEASE COURSE; HEART METASTASIS; HEMATOCHEZIA; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LYMPH NODE METASTASIS; MALE; MICROSCOPY; NEEDLE BIOPSY; PELVIS CANCER; PERITONEAL CAVITY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; RECTUM CARCINOMA; SMALL CELL CARCINOMA; SPINE METASTASIS;

AGED; CARCINOMA, SMALL CELL; FATAL OUTCOME; HUMANS; IMMUNOHISTOCHEMISTRY; INAPPROPRIATE ADH SYNDROME; MALE; NEUROENDOCRINE TUMORS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASOPRESSINS;

EID: 1642440056     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2003.01568.x     Document Type: Article

References (20)

1. di Sant'Agnese PA. Neuroendocrine differentiation in carcinoma of the prostate: diagnostic, prognostic, and therapeutic implications. Cancer (Suppl) 1992; 70: 254-68.
2. Leader M, Kay E, Walsh CB. Soft tissue neoplasms and other unusual tumors of prostate, including uncommon carcinomas. In: Foster CS, Bostwick DG, eds. Pathology of the Prostate. Philadelphia: Saunders, 1998; 364-83.
3. Wenk RE, Bhagavan BW, Levy R, Miller D, Weisburger WR. Ectopic ACTH, prostatic oat cell carcinoma and marked hypernatremia. Cancer 1977; 40: 773-8.
4. Helpap B, Köllermann J. Undifferentiated carcinoma of the prostate with small cell features: immunohistochemical subtyping and reflections on histogenesis. Virchows Arch 1999; 434: 385-91.
5. Schron DS, Gipson T, Mendelsohn G. The histogenesis of small cell carcinoma of the prostate: an immunohistochemical study. Cancer 1984; 53: 2478-80.
6. Turbat-Herrera EA, Herrera GA, Gore I, Lott RL, Grizzle WE, Bonnin JM. Neuroendocrine differentiation in prostatic carcinomas: a retrospective autopsy study. Arch Pathol Lab Med 1988; 112: 1100-5.
7. Weaver MG, Abdul-Karim FW, Srigley JR. Paneth cell-like change and small cell carcinoma of the prostate: two divergent forms of prostatic neuroendocrine differentiation. Am J Surg Pathol 1992; 16: 1013-16.
8. Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 1967; 42: 790-806.
9. Oesterling JE, Hauzeur CG, Farrow GM. Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients. J Urol 1992; 147: 804-7.
10. di Sant'Agnese PA. Neuroendocrine differentiation in human prostatic carcinoma. Hum Pathol 1992; 23: 287-96.
11. Abrahamsson PA. Neuroendocrine differentiation and hormone-refractory prostate cancer. Prostate (Suppl) 1996; 6: 3-8.
12. Miyoshi Y, Uemura H, Kitami K, Satomi Y, Kubota Y, Hosaka M. Neuroendocrine differentiated small cell carcinoma presenting as recurrent prostate cancer after androgen deprivation therapy. BJU Int 2001; 88: 982-3.
13. Tanaka M, Suzuki Y, Takaoka K et al. Progression of prostate cancer to neuroendocrine cell tumor. Int J Urol 2001; 8: 431-6.
14. Helpap B, Köllermann J, Oehler U. Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives. Urol Int 1999; 62: 133-8.
15. Heim M, Conte-Devolx B, Pin G et al. Syndrome de secretion inappropriee de vasopressine: apropos de troi observation. Sem Hop 1977; 53: 1155-9.
16. Ghandur-Mnaymneh L, Satterfield S, Block NL. Small cell carcinoma of the prostate gland with inappropriate antidiuretic hormone secretion: morphological, immunohistochemical and clinical expressions. J Urol 1986; 135: 1263-6.
17. Têtu B, Ro JY, Ayala AG, Johnson DE, Logothetis CJ, Ordonez NG. Small cell carcinoma of the prostate Part I: a clinicopathologic study of 20 cases. Cancer 1987; 59: 977-82.
18. Aprikian AG, Cordon-Cardo C, Fair WR, Reuter VE. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer 1993; 71: 3952-65.
19. Azumi N, Shibuya H, Ishikura M. Primary prostatic carcinoid tumor with intracytoplasmic prostatic acid phosphatase and prostate-specific antigen. Am J Surg Pathol 1984; 8: 545-51.
20. Wynn SS, Nagabundi S, Koo J, Chin NW. Recurrent prostate carcinoma presenting as omental large cell carcinoma with neuroendocrine differentiation and resulting in bowel obstruction. Arch Pathol Lab Med 2000; 124: 1074-6.